Prenylated flavonoids of the leaves of Macaranga conifera with inhibitory activity against cyclooxygenase-2

2002 ◽  
Vol 61 (7) ◽  
pp. 867-872 ◽  
Author(s):  
Dae Sik Jang ◽  
Muriel Cuendet ◽  
Michael E. Hawthorne ◽  
Leonardus B.S. Kardono ◽  
Kazuko Kawanishi ◽  
...  
2009 ◽  
Vol 17 (2) ◽  
pp. 106-110 ◽  
Author(s):  
W. Schühly ◽  
S. I. Khan ◽  
N. H. Fischer

2004 ◽  
Vol 47 (9) ◽  
pp. 2180-2193 ◽  
Author(s):  
Ramani R. Ranatunge ◽  
Michael Augustyniak ◽  
Upul K. Bandarage ◽  
Richard A. Earl ◽  
James L. Ellis ◽  
...  

2020 ◽  
Vol 39 ◽  
pp. 64-67
Author(s):  
Wen-Ting Fei ◽  
Jian-Jun Zhang ◽  
Ru-Ying Tang ◽  
Na Yue ◽  
Xue Zhou ◽  
...  

ChemInform ◽  
2008 ◽  
Vol 39 (28) ◽  
Author(s):  
JunPil Jang ◽  
MinKyun Na ◽  
Phuong Thien Thuong ◽  
Dieudonne Njamen ◽  
Joseph Tanyi Mbafor ◽  
...  

2008 ◽  
Vol 58 (3) ◽  
pp. 317-326 ◽  
Author(s):  
Rajesh Sharma ◽  
Jitendra Sainy ◽  
Subhash Chaturvedi

2-Amino-5-sulfanyl-1,3,4-thiadiazoles: A new series of selective cyclooxygenase-2 inhibitorsA new series of cyclooxygenase-2 inhibitors with 2-amino--5-sulfanyl-1,3,4-thiadiazole as the central scaffold unit has been synthesized. The newly synthesized compounds were characterized by analytical and spectral methods. Compounds were screened for cyclooxygenase inhibitory activity by the colorimetric COX (ovine) inhibitor screening assay, anti-inflammatory activity by the carrageenean induced rat paw oedema test and analgesic activity by the tail flick method. Some compounds exhibited significant biological activity.


2004 ◽  
Vol 12 (6) ◽  
pp. 1357-1366 ◽  
Author(s):  
Ramani R. Ranatunge ◽  
David S. Garvey ◽  
David R. Janero ◽  
L.Gordon Letts ◽  
Allison M. Martino ◽  
...  

2021 ◽  
Author(s):  
Jovica Branković ◽  
◽  
Vesna Milovanović ◽  
Vladimir P. Petrović

In the present work, a series of phenolic hydrazone analogs were investigated in silico for their potential inhibitory activity toward COX-2. These examinations were based on the capability of hydrazone-based compounds to interact with numerous enzymes, as well as on their versatile biological features and therapeutical applications. COX-2 was selected due to its involvement in the inflammation and carcinogenesis processes. Regarding this, COX-2 represents a valid target for the development of compounds that could block the formation of harmful inflammation mediators.


2015 ◽  
Vol 25 (17) ◽  
pp. 3455-3457 ◽  
Author(s):  
Yang Hee Jo ◽  
Seon Beom Kim ◽  
Qing Liu ◽  
Jin Woo Lee ◽  
Bang Yeon Hwang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document